Kineta rises on narrower Q1 loss
17/05/2023 17:58
** Shares of clinical-stage biotechnology co Kineta Inc
KA.O up 1.6% at $2.15
** Q1 net loss was 77 cents/share vs loss of $1.07/share
last year urn:newsml:reuters.com:*:nGNX3Sp892
** Co ended March quarter with cash balance of $9.2 mln
** Says cash position, together with other net proceeds
received in 2023, to provide runway through early 2025
** Shares down ~51% YTD
(Reporting by Yamini Kalia in Bengaluru)
((Yamini.Kalia@thomsonreuters.com))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study